Abuse and dependence liability of benzodiazepine-type drugs: GABAA receptor modulation and beyond
- 1 July 2008
- journal article
- review article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 90 (1) , 74-89
- https://doi.org/10.1016/j.pbb.2008.01.001
Abstract
No abstract availableKeywords
This publication has 210 references indexed in Scilit:
- Dynorphin and the pathophysiology of drug addictionPharmacology & Therapeutics, 2007
- GABAA receptor diversity and pharmacologyCell and tissue research, 2006
- Intra-ventral tegmental area heroin-induced place preferences in rats are potentiated by peripherally administered alprazolamPharmacology Biochemistry and Behavior, 2005
- Which GABAA-receptor subtypes really occur in the brain?Trends in Neurosciences, 1996
- A rapid screening method for the assessment of benzodiazepine receptor-related physical dependence in mice: Evaluation of benzodiazepine-related agonists and partial agonistsJournal of Pharmacological Methods, 1991
- Chronic Benzodiazepine Administration: From the Patient to the GeneThe Journal of Clinical Pharmacology, 1991
- Abuse Liability of Barbiturates and Other Sedative-HypnoticsAdvances in Alcohol & Substance Abuse, 1990
- Midazolam A Review of its Pharmacological Properties and Therapeutic UseDrugs, 1984
- Diazepam use among methadone maintenance patients: Patterns and dosagesDrug and Alcohol Dependence, 1981
- GABAergic modulation of benzodiazepine binding site sensitivityNature, 1978